Recent News

• 06.10.2025 - Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
• 06.02.2025 - Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
• 05.14.2025 - Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
• 05.06.2025 - Neuronetics Reports First Quarter 2025 Financial and Operating Results
• 05.05.2025 - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 04.22.2025 - Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

Recent Filings

• 06.02.2025 - SD Specialized disclosure report
• 05.28.2025 - 8-K Current report
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 144 Report of proposed sale of securities